FDA's Blood Products Advisory Cmte.

Executive Summary

Second day of Sept. 17-18 meeting will take place at Parklawn Building, Conference Rooms G & H, not at Office of Biologics Research, as was previously scheduled. First day will still take place at Office of Biologics Research, located on the NIH campus. Public portions of the meeting will discuss reevaluation methods for persons who are currently deferred from donating blood because of reactive hepatitis B surface antigen tests. Public sessions begin at 9:00 A.M. on Sept. 17 and 8:00 A.M. on Sept. 18.